Factor Xa and thrombin (factor IIa) activate factor VIII (fVIII) by di
fferent proteolytic pathways. Thrombin cleaves fVIII at Arg372 between
the Al and A2 domains, at Arg740 between the A2 and B domains, and at
Arg1689 between the B and A3 domains to form an A1/A2/A3-C1-C2 hetero
trimer. We now report a stable porcine fVIIIa(Xa) preparation obtained
by Mono S HPLC at pH 6. NH2-terminal sequence analysis of purified su
bunits of fVIIIa(Xa) revealed that factor Xa cleaves fVIII at Arg219 w
ithin the Al domain and at Arg490 within the A2 domain, as well as at
Arg372, Arg740, and Arg1689. Analytical ultracentrifugation of the fVI
IIa(Xa) preparation yielded results consistent with a single, 148 kDa
species, similar to previous results with fVIIIa(IIa) [Lollar, P., & P
arker, C. G. (1989) Biochemistry 28, 666-674]. Thus, the major species
in the fVIIIa(Xa),preparation contains five subunits, including fragm
ents of the Al and A2 domains that remain noncovalently bound. Fluores
cence anisotropy measurements indicated there was no difference in the
affinity of fVIIIa(Xa) and fVIIIa(IIa) for a fluorescent dye-labeled,
active-site-blocked derivative of porcine factor IXa. Additionally, t
he fVIIIa(Xa), preparation bound dye-labeled factor IXa with 1:1 stoic
hiometry, indicating that all fVIIIa(Xa) molecules in the preparation
can bind factor IXa. However, fVIIIa(Xa) had 4-fold less procoagulant
activity than fVIIIa(IIa). Kinetic analysis of fVIIIa cofactor activit
y using purified factor IXa and factor X suggested this difference is
due to greater activity of fVIIIa(IIa) relative to fVIIIa(Xa) within t
he intrinsic fXase complex, rather than a difference in their stabilit
ies.